We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$495M
AUM Growth
+$15.3M
Cap. Flow
-$3.32M
Cap. Flow %
-0.67%
Top 10 Hldgs %
32.03%
Holding
182
New
34
Increased
14
Reduced
51
Closed
25

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$11.4M
2
AMAT icon
Applied Materials
AMAT
+$11.3M
3
MCK icon
McKesson
MCK
+$11.2M
4
BUD icon
AB InBev
BUD
+$11.1M
5
KO icon
Coca-Cola
KO
+$9.99M

Top Sells

Rank Stock Value
1
ALV icon
Autoliv
ALV
+$12.5M
2
HAL icon
Halliburton
HAL
+$11.1M
3
BSX icon
Boston Scientific
BSX
+$10.4M
4
BDC icon
Belden
BDC
+$9.87M
5
GG
Goldcorp Inc
GG
+$9.47M

Sector Composition

Rank Sector Weight
1 Healthcare 23.73%
2 Technology 19.2%
3 Industrials 9.85%
4 Materials 9.55%
5 Consumer Staples 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLY icon
126
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$9K ﹤0.01%
+260
New +$8.91K
AAPL icon
127
Apple
AAPL
$4.57T
$8K ﹤0.01%
308
– –
AXS icon
128
AXIS Capital
AXS
$7.55B
$8K ﹤0.01%
+150
New +$7.34K
EW icon
129
Edwards Lifesciences
EW
$51.7B
$8K ﹤0.01%
360
– –
INTC icon
130
Intel
INTC
$513B
$8K ﹤0.01%
230
– –
NLY icon
131
Annaly Capital Management
NLY
$17.4B
$8K ﹤0.01%
188
+58
+45% +$2.62K
SH icon
132
ProShares Short S&P500
SH
$897M
$8K ﹤0.01%
46
– –
UNH icon
133
UnitedHealth
UNH
$370B
$8K ﹤0.01%
80
– –
VRTX icon
134
Vertex Pharmaceuticals
VRTX
$126B
$8K ﹤0.01%
65
– –
VZ icon
135
Verizon
VZ
$196B
$8K ﹤0.01%
+171
New +$8.37K
PRE
136
DELISTED
PARTNERRE LTD
PRE
$8K ﹤0.01%
+70
New +$7.98K
BCR
137
DELISTED
CR Bard Inc.
BCR
$8K ﹤0.01%
50
– –
AGX icon
138
Argan
AGX
$8.37B
$7K ﹤0.01%
220
– –
CF icon
139
CF Industries
CF
$17.3B
$7K ﹤0.01%
125
– –
CI icon
140
Cigna
CI
$74.6B
$7K ﹤0.01%
70
– –
EIX icon
141
Edison International
EIX
$26.4B
$7K ﹤0.01%
100
– –
IGIB icon
142
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$7K ﹤0.01%
124
-200
-62% -$11K
TSN icon
143
Tyson Foods
TSN
$20.4B
$7K ﹤0.01%
180
– –
FGP
144
DELISTED
Ferrellgas Partners, L.P.
FGP
$7K ﹤0.01%
+300
New +$7.85K
CE icon
145
Celanese
CE
$4.82B
$6K ﹤0.01%
100
– –
MYGN icon
146
Myriad Genetics
MYGN
$312M
$6K ﹤0.01%
175
– –
ARLP icon
147
Alliance Resource Partners
ARLP
$3.17B
$5K ﹤0.01%
125
– –
CVI icon
148
CVR Energy
CVI
$3.13B
$5K ﹤0.01%
135
– –
DD icon
149
DuPont de Nemours
DD
$19.2B
$5K ﹤0.01%
47
– –
WNR
150
DELISTED
Western Refining Inc
WNR
$5K ﹤0.01%
140
– –
4 5
6
7 8

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Contravisory Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Contravisory Investment Management held 182 positions worth $495M, up 3.2% from $480M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Contravisory Investment Management's Q4 2014 filing shows 34 new, 14 increased, 51 reduced and 25 closed positions. Its largest new stake was Johnson & Johnson: 107,956 shares worth $11.3M. The largest sale was Autoliv, an estimated $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Contravisory Investment Management's largest Q4 2014 buy was Johnson & Johnson: 107,956 shares worth $11.3M.
  • Contravisory Investment Management added most to AB InBev in Q4 2014, an estimated $11.1M increase.
  • Contravisory Investment Management's biggest Q4 2014 reduction was Autoliv, cutting an estimated $12.5M.
  • Contravisory Investment Management fully exited Eversource Energy in Q4 2014, selling an estimated $724K.
  • Contravisory Investment Management's ten largest holdings make up 32% of its $495M portfolio in Q4 2014.
  • Contravisory Investment Management opened 34 new positions and closed 25 in Q4 2014.
  • Contravisory Investment Management's portfolio value rose 3.2% quarter-over-quarter to $495M.

Based on Contravisory Investment Management's 13F filing for Q4 2014, filed 12 Jan 2015.